The Valeda Light Delivery System is for the treatment of patients with dry age-related macular degeneration (AMD).

The report notes that large employers' perceptions about PBM performance have not changed much over the past 5 years. Employers continue to be more satisfied with core PBM services and ...

Joyner’s comments were his first made publicly since he was promoted less than a month ago to replace Karen S. Lynch, who stepped down. CVS Health has struggled to control costs in its Aetna health ...

LumiThera Inc., a medical device company offering photobiomodulation (PBM) treatment for ocular ... must show similar clinical and nonclinical performance controls equivalent to the Valeda Light ...

CVS Health fell short on third-quarter profit, but it posted strong sales and the health care giant shook up leadership under ...

CVS Health fell short on third-quarter profit, but it posted strong sales and the health care giant shook up leadership under ...

CVS Health today announced Prem Shah will be group president, and will continue to report to David Joyner, president and CEO. In addition, the company announced the appointment of Steve Nelson as ...

CVS Health faced mixed results in its latest earnings report, revealing revenue growth amid segment struggles.

Does a PBM take a proactive approach to provide service ... Pharmacy benefit plan monitoring and reporting helps brokers and employers to improve performance of the plan when needed. By including ...

I have spent my career fighting for the hardworking people of our state—especially those who need our support the most.

CVS Health runs one of the nation’s largest drugstore chains and a huge pharmacy benefit management business ... business has dragged on the company's performance and many see in Nelson an ...